drugset / Trial / NCT06237049

A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

NCT06237049

Phase 2 Completed 644 enrolled Pfizer
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this clinical trial is to see if combining a licensed COVID-19 vaccine and a licensed influenza vaccine into a single shot is safe and can help produce antibodies to defend the body against both SARS-CoV-2 (the virus that causes COVID-19) and influenza. Participants enrolled in this trial will be healthy adults, 50 years of age or older.

Timeline

Start
2024-01-31
Primary completion
2024-09-13
Completion
2024-09-13

Drugs

EvaluationDrugModalityDoseRoute
Subject BNT162b2 Messenger RNA (mRNA)
Subject RIV Vaccine

Indications